Abstract:Trauma is a leading cause of death in the United States. Advancements in shock resuscitation have been disappointing because the correct upstream mechanisms of injury are not being targeted. Recently, significant advancements have been shown using new cell-impermeant molecules that work by transferring metabolic water from swollen ischemic cells to the capillary, which restores tissue perfusion by microcirculatory decompression. The rapid normalization of oxygen transfer improves resuscitation outcomes. Since poor resuscitation and perfusion of trauma patients also causes critical illness and sepsis and can be mimicked by ischemia-reperfusion of splanchnic tissues, we hypothesized that inadequate oxygenation of the gut during trauma drives development of later shock and critical illness. We further hypothesized that this is caused by ischemia-induced water shifts causing compression no-reflow. To test this, the superior mesenteric artery of juvenile anesthetized swine was occluded for 30 minutes followed by 8 hours of reperfusion to induce mild splanchnic artery occlusion (SAO) shock. One group received the impermeant polyethylene glycol 20,000 Da (PEG-20k) that prevents metabolic cell swelling, and the other received a lactated Ringer's vehicle. Survival doubled in PEG-20k-treated swine along with improved macrohemodynamics and intestinal mucosal perfusion. Villus morphometry and plasma inflammatory cytokines normalized with impermeants. Plasma endotoxin rose over time after reperfusion, and impermeants abolished the rise. Inert osmotically active cell impermeants like PEG-20k improve intestinal reperfusion injury, SAO shock, and early signs of sepsis, which may be due to early restoration of mucosal perfusion and preservation of the septic barrier by reversal of ischemic compression no-reflow. SIGNIFICANCE STATEMENT: Significant advancements in treating shock and ischemia have been disappointing because the correct upstream causes have not been targeted. This study supports that poor tissue perfusion after intestinal ischemia from shock is caused by capillary compression no-reflow secondary to metabolic cell and tissue swelling since selectively targeting this issue with novel polyethylene glycol 20,000 Da-based cell-impermeant intravenous solutions reduces splanchnic artery occlusion shock, doubles survival time, restores tissue microperfusion, and preserves gut barrier function.

Regulatory mechanisms, prophylaxis and treatment of vascular leakage following severe trauma and shock

Vascular leak in sepsis: physiological basis and potential therapeutic advances

Study of vascular injuries using endothelial denudation model and the therapeutic application of shock wave: a review

Progress of Clinical Reaearch on Capillary Leak Syndrome

Endothelial barrier dysfunction in septic shock

Injury Mechanism of Lung Vascular Endothelial Permeability Function in Acute Lung Injury and Acute Respiratory Distress Syndrome

A Systematic Review of Neuroprotective Strategies during Hypovolemia and Hemorrhagic Shock

Pathophysiology in patients with polytrauma

Navigating Hemorrhagic Shock: Biomarkers, Therapies, and Challenges in Clinical Care

The Mechanisms of Cerebral Vasospasm Caused by Subarachnoid Hemorrhage and Its Clinical Treatment Progress

Research progress in pathogenic mechanism of hemorrhagic shock-induced acute lung injury/acute respiratory distress syndrome

Advances in the research of effects of cholinergic anti-inflammatory pathway on vital organ function and its mechanism

Metabolic Tissue Swelling and Local Microcirculation in Splanchnic Artery Occlusion Shock: Implications for Critical Illness

Venous system in acute brain injury: Mechanisms of pathophysiological change and function.

Therapeutic Potential of Mesenchymal Stromal Cell-Derived Extracellular Vesicles in the Prevention of Organ Injuries Induced by Traumatic Hemorrhagic Shock

Better Therapy for Combat Injury

New advances in the treatments of traumatic hemorrhagic shock

Sepsis and septic shock: pathophysiological and cardiovascular background as basis for therapy

Blood–brain barrier dysfunction following traumatic brain injury

Evaluation of Vasoactive Agents on Microcirculatory Disturbance in Shock Patients

The Pathogenesis and Treatment of Vascular Hyporeactivity in Severe Hemorrhagic Shock